Author
Listed:
- Mohsen Pourmousa
(9800 Medical Center Drive)
- Sankalp Jain
(9800 Medical Center Drive)
- Elena Barnaeva
(9800 Medical Center Drive)
- Wengong Jin
(Massachusetts Institute of Technology)
- Joshua Hochuli
(University of North Carolina)
- Zina Itkin
(9800 Medical Center Drive)
- Travis Maxfield
(University of North Carolina)
- Cleber Melo-Filho
(University of North Carolina)
- Andrew Thieme
(University of North Carolina)
- Kelli Wilson
(9800 Medical Center Drive)
- Carleen Klumpp-Thomas
(9800 Medical Center Drive)
- Sam Michael
(9800 Medical Center Drive)
- Noel Southall
(9800 Medical Center Drive)
- Tommi Jaakkola
(Massachusetts Institute of Technology)
- Eugene N. Muratov
(University of North Carolina
LLC)
- Regina Barzilay
(Massachusetts Institute of Technology)
- Alexander Tropsha
(University of North Carolina
LLC)
- Marc Ferrer
(9800 Medical Center Drive)
- Alexey V. Zakharov
(9800 Medical Center Drive)
Abstract
Pancreatic cancer treatment often relies on multi-drug regimens, but optimal combinations remain elusive. This study evaluates predictive approaches to identify synergistic drug combinations using a dataset from the National Center for Advancing Translational Sciences (NCATS). Screening 496 combinations of 32 anticancer compounds against the PANC-1 cells experimentally determined the degree of synergism and antagonism. Three research groups (NCATS, University of North Carolina, and Massachusetts Institute of Technology) leverage these data to apply machine learning (ML) approaches, predicting synergy across 1.6 million combinations. Of the 88 tested, 51 show synergy, with graph convolutional networks achieving the best hit rate and random forest the highest precision. Beyond highlighting the potential of ML, this work delivers 307 experimentally validated synergistic combinations, demonstrating its practical impact in treating pancreatic cancer.
Suggested Citation
Mohsen Pourmousa & Sankalp Jain & Elena Barnaeva & Wengong Jin & Joshua Hochuli & Zina Itkin & Travis Maxfield & Cleber Melo-Filho & Andrew Thieme & Kelli Wilson & Carleen Klumpp-Thomas & Sam Michael , 2025.
"AI-driven discovery of synergistic drug combinations against pancreatic cancer,"
Nature Communications, Nature, vol. 16(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56818-6
DOI: 10.1038/s41467-025-56818-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56818-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.